Expression of CD66c is correlated with BCR::ABL1 and hyperdiploid cytogenetics [67,68,69], and expression of CD66c was not observed in CD10-negative/KMT2A-rearranged BCP-ALL patients [65,68]. Here, CEACAM6 is linked to acute lymphoblastic leukemia.